GlassScriptPhysician profile
Susanne Goeb
NPI 1992896708
$9,686.07
in general payments reported to CMS, 2019-2025
68 companies · $1,218 in 2025
The $1,218 reported for 2025 was more than what 86% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,518 · 2022: $1,856 · 2023: $2,059 · 2024: $2,035 · 2025: $1,218.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,312.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,312.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,525.35 | 2021-2025 | |
| Pfizer INC. | $585.43 | 2021-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $485.37 | 2021-2025 | Xifaxan, Trulance |
| Otsuka America Pharmaceutical, INC. | $483.57 | 2021-2024 | Rexulti |
| Amgen INC. | $445.17 | 2021-2025 | Otezla, Otezla, Repatha |
| Novartis Pharmaceuticals Corporation | $423.97 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $397.29 | 2021-2025 | Breztri, Airsupra, Farxiga |
| Glaxosmithkline, LLC. | $387.26 | 2021-2024 | Trelegy Ellipta, Shingrix, Arexvy |
| Esperion Therapeutics, INC. | $377.68 | 2021-2025 | Nexletol |
| Boehringer Ingelheim Pharmaceuticals, INC. | $349.73 | 2021-2024 | Jardiance, Synjardy |
| Bayer Healthcare Pharmaceuticals INC. | $231.23 | 2021-2023 | |
| Novo Nordisk INC | $218.35 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Bausch Health US, LLC | $207.44 | 2021-2024 | Aplenzin |
| Merck Sharp & Dohme LLC | $197.25 | 2021-2025 | Gardasil 9, Gardasil, Capvaxive |
| Biohaven Pharmaceuticals, INC. | $190.90 | 2021 |
Show all 68 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susanne Goeb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.